Sugi Predict

Sugi Predict / Compounds / SCHEMBL15834147

SCHEMBL15834147

SCHEMBL15834147

CCOC(=O)CC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.44
▸ GAA P10253 2/20 0.43
▸ MGAM O43451 1/20 0.43
▸ SI P14410 1/20 0.43
▸ MGAM2 Q2M2H8 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.40
▸ TRPA1 O75762 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP4F2 P78329 2/20 0.37
▸ CYP4A11 Q02928 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9705684 0.82 CYP1A2 (0.45) CYP1A2GAAMGAMSIMGAM2
SCHEMBL2885818 0.79 GAA (0.50) CYP1A2GAAMGAMSIMGAM2
SCHEMBL13151035 0.77 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2
SCHEMBL9227285 0.77 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2
SCHEMBL13151108 0.75 CYP1A2 (0.47) CYP1A2GAAMGAMSIMGAM2
SCHEMBL26454720 0.75 CYP1A2 (0.47) CYP1A2GAAMGAMSIMGAM2
SCHEMBL13151056 0.73 ALDH1A1 (0.46) CYP1A2GAAMGAMSIMGAM2
SCHEMBL19858542 0.72 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2
SCHEMBL26454470 0.72 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2
SCHEMBL10957393 0.72 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935287-B1 METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND BLUESTAR SILICONES FRANCE (FR) 2016-12-14 — — EP disclosed
US-9475829-B2 Method for the hydrosilylation of a siloxane photocatalysed by a polyoxometalate compound BLUESTAR SILICONES FRANCE SAS (FR) 2016-10-25 — — US disclosed
US-20150315214-A1 METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND BLUESTAR SILICONES FRANCE SAS (FR) 2015-11-05 — — US disclosed
WO-2014096721-A1 METHOD FOR PREPARING FUNCTIONALISED POLYORGANOSILOXANES BLUESTAR SILICONES FRANCE SAS (FR) 2014-06-26 — — WO disclosed
WO-2014096720-A1 METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND BLUESTAR SILICONES FRANCE SAS (FR) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150315214-A1 METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND HAO2, HAAO, PPOX CYP1A2 1159/4885GAA 1950/4885MGAM 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.